Vice President, Clinical Operations at Myrtelle
Cheryl Demos Fludas serves as Vice President, Clinical Operations at Myrtelle, where she oversees clinical trial implementation and vendor management. Cheryl joined the Company in 2022, bringing more than 25 years of experience in clinical operations management roles across a multitude of therapeutic indications in pharma and in the CRO space. Cheryl recently served as Clinical Operations Program Lead for two rare disease indications while at Novartis Gene Therapies (formerly AveXis). Cheryl holds a B.A. in Classics from Loyola University of Chicago.
Cheryl is drawn to the fast-paced energy and challenges of the biotech sector and being part of the development of innovative therapies for rare diseases.
Cheryl enjoys live music and theater in Chicago, travel, cooking and entertaining for friends and family.